Home
Target list
Statistics
Structure galleries
Target nomination
Technologies
Web tools
Databases
Participating investigators
Publications
|
NESG statistics
NESG (complete history)
Production stage
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
25,924 |
41,201 |
19,048 |
Expression tested |
|
  |
24,479 |
38,088 |
17,773 |
Expressed (E > 0) |
|
  |
18,992 |
27,456 |
14,318 |
Expressed-Soluble (S > 0) |
|
  |
13,946 |
18,556 |
11,403 |
Expressed-Soluble (ES >= 9) |
|
  |
11,054 |
14,480 |
9,219 |
Fermented |
|
  |
9,440 |
12,040 |
8,259 |
Purification attempted |
|
  |
8,691 |
10,768 |
7,687 |
Purified (>= 0.5 mg yield) |
|
  |
6,493 |
7,807 |
5,726 |
HSQC spectra recorded |
|
  |
2,853 |
3,642 |
2,536 |
"Good" HSQC spectra |
|
  |
1,476 |
1,848 |
1,323 |
HTP crystal screening |
|
  |
2,845 |
3,370 |
2,573 |
Crystal hit |
|
  |
1,480 |
1,672 |
1,373 |
X-Ray structures |
|
  |
608 |
615 |
597 | 664 |
NMR structures |
|
  |
496 |
498 |
488 | 535 | 43 |
Total structures |
|
  |
1,061 |
1,078 |
1,034 | 1,199 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [activity table created 2016-04-29]
NESG (PSI-1)
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
5,790 |
7,957 |
5,603 |
Expression tested |
|
  |
4,698 |
5,929 |
4,569 |
Expressed (E > 0) |
|
  |
3,321 |
3,606 |
3,261 |
Expressed-Soluble (S > 0) |
|
  |
2,526 |
2,724 |
2,498 |
Expressed-Soluble (ES >= 9) |
|
  |
2,026 |
2,150 |
2,009 |
Fermented |
|
  |
2,412 |
3,044 |
2,372 |
Purification attempted |
|
  |
2,159 |
2,598 |
2,123 |
Purified (>= 0.5 mg yield) |
|
  |
1,088 |
1,121 |
1,086 |
HSQC spectra recorded |
|
  |
791 |
1,094 |
788 |
"Good" HSQC spectra |
|
  |
344 |
484 |
342 |
HTP crystal screening |
|
  |
268 |
268 |
268 |
Crystal hit |
|
  |
146 |
146 |
146 |
X-Ray structures |
|
  |
112 |
112 |
112 | 115 |
NMR structures |
|
  |
80 |
80 |
80 | 83 | 2 |
Total structures |
|
  |
190 |
190 |
190 | 198 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [activity table created 2016-04-29]
NESG (PSI-2)
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
15,302 |
21,621 |
11,016 |
Expression tested |
|
  |
14,490 |
20,236 |
10,334 |
Expressed (E > 0) |
|
  |
10,901 |
14,393 |
8,211 |
Expressed-Soluble (S > 0) |
|
  |
8,242 |
10,348 |
6,711 |
Expressed-Soluble (ES >= 9) |
|
  |
6,540 |
8,101 |
5,383 |
Fermented |
|
  |
4,214 |
4,999 |
3,602 |
Purification attempted |
|
  |
4,232 |
4,968 |
3,663 |
Purified (>= 0.5 mg yield) |
|
  |
3,213 |
3,771 |
2,754 |
HSQC spectra recorded |
|
  |
1,439 |
1,694 |
1,239 |
"Good" HSQC spectra |
|
  |
808 |
952 |
712 |
HTP crystal screening |
|
  |
1,932 |
2,227 |
1,728 |
Crystal hit |
|
  |
1,035 |
1,149 |
945 |
X-Ray structures |
|
  |
372 |
375 |
366 | 397 |
NMR structures |
|
  |
298 |
299 |
294 | 309 | 31 |
Total structures |
|
  |
639 |
649 |
622 | 706 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [activity table created 2016-04-30]
NESG (PSI-Biology)
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
6,868 |
13,843 |
4,563 |
Expression tested |
|
  |
6,404 |
12,873 |
4,169 |
Expressed (E > 0) |
|
  |
5,633 |
10,286 |
3,834 |
Expressed-Soluble (S > 0) |
|
  |
3,981 |
6,293 |
3,053 |
Expressed-Soluble (ES >= 9) |
|
  |
3,160 |
4,919 |
2,536 |
Fermented |
|
  |
3,348 |
4,451 |
2,877 |
Purification attempted |
|
  |
2,997 |
3,804 |
2,648 |
Purified (>= 0.5 mg yield) |
|
  |
2,609 |
3,287 |
2,334 |
HSQC spectra recorded |
|
  |
732 |
944 |
642 |
"Good" HSQC spectra |
|
  |
379 |
460 |
334 |
HTP crystal screening |
|
  |
736 |
928 |
679 |
Crystal hit |
|
  |
347 |
410 |
338 |
X-Ray structures |
|
  |
134 |
138 |
131 | 152 |
NMR structures |
|
  |
134 |
134 |
131 | 143 | 6 |
Total structures |
|
  |
262 |
267 |
256 | 295 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [activity table created 2016-04-30]
Human proteins
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
6,879 |
13,870 |
4,274 |
Expression tested |
|
  |
6,544 |
13,073 |
3,999 |
Expressed (E > 0) |
|
  |
5,381 |
9,747 |
3,432 |
Expressed-Soluble (S > 0) |
|
  |
3,462 |
5,613 |
2,496 |
Expressed-Soluble (ES >= 9) |
|
  |
2,595 |
4,165 |
1,957 |
Fermented |
|
  |
2,665 |
3,590 |
2,159 |
Purification attempted |
|
  |
2,367 |
3,053 |
1,980 |
Purified (>= 0.5 mg yield) |
|
  |
1,991 |
2,559 |
1,697 |
HSQC spectra recorded |
|
  |
529 |
743 |
419 |
"Good" HSQC spectra |
|
  |
287 |
369 |
234 |
HTP crystal screening |
|
  |
413 |
587 |
333 |
Crystal hit |
|
  |
164 |
195 |
142 |
X-Ray structures |
|
  |
42 |
45 |
41 | 48 |
NMR structures |
|
  |
91 |
91 |
86 | 92 | 8 |
Total structures |
|
  |
125 |
130 |
118 | 140 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Eukaryotic proteins
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
8,176 |
17,111 |
5,372 |
Expression tested |
|
  |
7,567 |
15,493 |
4,831 |
Expressed (E > 0) |
|
  |
6,105 |
11,332 |
4,000 |
Expressed-Soluble (S > 0) |
|
  |
3,967 |
6,517 |
2,905 |
Expressed-Soluble (ES >= 9) |
|
  |
2,971 |
4,831 |
2,264 |
Fermented |
|
  |
3,276 |
4,642 |
2,723 |
Purification attempted |
|
  |
2,961 |
3,949 |
2,549 |
Purified (>= 0.5 mg yield) |
|
  |
2,153 |
2,821 |
1,839 |
HSQC spectra recorded |
|
  |
722 |
1,109 |
608 |
"Good" HSQC spectra |
|
  |
352 |
488 |
296 |
HTP crystal screening |
|
  |
436 |
615 |
351 |
Crystal hit |
|
  |
172 |
203 |
150 |
X-Ray structures |
|
  |
48 |
51 |
47 | 57 |
NMR structures |
|
  |
117 |
117 |
112 | 120 | 8 |
Total structures |
|
  |
157 |
162 |
150 | 177 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Prokaryotic proteins
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
17,748 |
24,090 |
13,677 |
Expression tested |
|
  |
16,912 |
22,596 |
12,943 |
Expressed (E > 0) |
|
  |
12,887 |
16,124 |
10,319 |
Expressed-Soluble (S > 0) |
|
  |
9,979 |
12,039 |
8,499 |
Expressed-Soluble (ES >= 9) |
|
  |
8,083 |
9,649 |
6,956 |
Fermented |
|
  |
6,164 |
7,399 |
5,537 |
Purification attempted |
|
  |
5,730 |
6,821 |
5,139 |
Purified (>= 0.5 mg yield) |
|
  |
4,341 |
4,988 |
3,888 |
HSQC spectra recorded |
|
  |
2,131 |
2,533 |
1,929 |
"Good" HSQC spectra |
|
  |
1,124 |
1,360 |
1,027 |
HTP crystal screening |
|
  |
2,409 |
2,756 |
2,222 |
Crystal hit |
|
  |
1,308 |
1,470 |
1,223 |
X-Ray structures |
|
  |
560 |
564 |
550 | 608 |
NMR structures |
|
  |
379 |
381 |
376 | 415 | 35 |
Total structures |
|
  |
904 |
916 |
884 | 1,023 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
CRSH
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
176 |
395 |
142 |
Expression tested |
|
  |
176 |
395 |
142 |
Expressed (E > 0) |
|
  |
152 |
308 |
123 |
Expressed-Soluble (S > 0) |
|
  |
127 |
217 |
110 |
Expressed-Soluble (ES >= 9) |
|
  |
112 |
184 |
101 |
Fermented |
|
  |
116 |
167 |
105 |
Purification attempted |
|
  |
92 |
131 |
85 |
Purified (>= 0.5 mg yield) |
|
  |
82 |
114 |
75 |
HSQC spectra recorded |
|
  |
18 |
28 |
18 |
"Good" HSQC spectra |
|
  |
10 |
14 |
10 |
HTP crystal screening |
|
  |
60 |
77 |
57 |
Crystal hit |
|
  |
32 |
40 |
32 |
X-Ray structures |
|
  |
7 |
7 |
7 | 7 |
NMR structures |
|
  |
1 |
1 |
1 | 1 |
Total structures |
|
  |
8 |
8 |
8 | 8 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
PSI-2 BIG domains assigned to NESG
PSI-2 BIG domains
Ubiquitin-like domains
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
202 |
464 |
152 |
Expression tested |
|
  |
192 |
426 |
150 |
Expressed (E > 0) |
|
  |
153 |
299 |
128 |
Expressed-Soluble (S > 0) |
|
  |
126 |
218 |
103 |
Expressed-Soluble (ES >= 9) |
|
  |
111 |
183 |
89 |
Fermented |
|
  |
81 |
129 |
69 |
Purification attempted |
|
  |
81 |
120 |
69 |
Purified (>= 0.5 mg yield) |
|
  |
61 |
87 |
51 |
HSQC spectra recorded |
|
  |
54 |
76 |
46 |
"Good" HSQC spectra |
|
  |
37 |
49 |
31 |
HTP crystal screening |
|
  |
26 |
34 |
23 |
Crystal hit |
|
  |
12 |
14 |
12 |
X-Ray structures |
|
  |
4 |
4 |
4 | 5 |
NMR structures |
|
  |
19 |
19 |
18 | 20 | 2 |
Total structures |
|
  |
21 |
22 |
20 | 25 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Human Ubiquitin-like domains
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
86 |
222 |
62 |
Expression tested |
|
  |
76 |
197 |
60 |
Expressed (E > 0) |
|
  |
64 |
146 |
54 |
Expressed-Soluble (S > 0) |
|
  |
46 |
87 |
38 |
Expressed-Soluble (ES >= 9) |
|
  |
38 |
69 |
31 |
Fermented |
|
  |
33 |
54 |
26 |
Purification attempted |
|
  |
38 |
58 |
30 |
Purified (>= 0.5 mg yield) |
|
  |
27 |
42 |
21 |
HSQC spectra recorded |
|
  |
22 |
32 |
18 |
"Good" HSQC spectra |
|
  |
16 |
22 |
13 |
HTP crystal screening |
|
  |
9 |
14 |
7 |
Crystal hit |
|
  |
4 |
6 |
4 |
X-Ray structures |
|
  |
2 |
2 |
2 | 3 |
NMR structures |
|
  |
7 |
7 |
6 | 7 | 1 |
Total structures |
|
  |
8 |
9 |
7 | 10 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
D. Baker outreach targets
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
416 |
430 |
394 |
Expression tested |
|
  |
381 |
390 |
370 |
Expressed (E > 0) |
|
  |
341 |
345 |
331 |
Expressed-Soluble (S > 0) |
|
  |
333 |
336 |
323 |
Expressed-Soluble (ES >= 9) |
|
  |
307 |
309 |
298 |
Fermented |
|
  |
361 |
363 |
351 |
Purification attempted |
|
  |
315 |
315 |
306 |
Purified (>= 0.5 mg yield) |
|
  |
300 |
300 |
291 |
HSQC spectra recorded |
|
  |
137 |
137 |
131 |
"Good" HSQC spectra |
|
  |
76 |
76 |
71 |
HTP crystal screening |
|
  |
251 |
251 |
243 |
Crystal hit |
|
  |
136 |
136 |
134 |
X-Ray structures |
|
  |
52 |
52 |
51 | 58 |
NMR structures |
|
  |
21 |
21 |
21 | 23 |
Total structures |
|
  |
73 |
73 |
72 | 81 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
HCPIN (Human Cancer Interaction Networks)
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
3,260 |
8,121 |
1,559 |
Expression tested |
|
  |
3,226 |
7,976 |
1,548 |
Expressed (E > 0) |
|
  |
2,711 |
5,957 |
1,445 |
Expressed-Soluble (S > 0) |
|
  |
1,759 |
3,326 |
1,091 |
Expressed-Soluble (ES >= 9) |
|
  |
1,367 |
2,511 |
889 |
Fermented |
|
  |
1,113 |
1,766 |
780 |
Purification attempted |
|
  |
959 |
1,461 |
695 |
Purified (>= 0.5 mg yield) |
|
  |
823 |
1,245 |
614 |
HSQC spectra recorded |
|
  |
397 |
579 |
307 |
"Good" HSQC spectra |
|
  |
231 |
301 |
187 |
HTP crystal screening |
|
  |
315 |
453 |
249 |
Crystal hit |
|
  |
131 |
153 |
110 |
X-Ray structures |
|
  |
29 |
29 |
28 | 30 |
NMR structures |
|
  |
71 |
71 |
68 | 72 | 6 |
Total structures |
|
  |
94 |
96 |
89 | 102 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Mitochondrial Proteome Partnership
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
648 |
1,815 |
311 |
Expression tested |
|
  |
627 |
1,713 |
299 |
Expressed (E > 0) |
|
  |
505 |
1,182 |
262 |
Expressed-Soluble (S > 0) |
|
  |
351 |
654 |
216 |
Expressed-Soluble (ES >= 9) |
|
  |
290 |
523 |
190 |
Fermented |
|
  |
253 |
429 |
170 |
Purification attempted |
|
  |
194 |
319 |
137 |
Purified (>= 0.5 mg yield) |
|
  |
178 |
279 |
128 |
HSQC spectra recorded |
|
  |
57 |
91 |
44 |
"Good" HSQC spectra |
|
  |
21 |
33 |
14 |
HTP crystal screening |
|
  |
74 |
107 |
61 |
Crystal hit |
|
  |
19 |
29 |
18 |
X-Ray structures |
|
  |
3 |
6 |
3 | 6 |
NMR structures |
|
  |
4 |
4 |
3 | 4 |
Total structures |
|
  |
7 |
10 |
6 | 10 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Mitochondrial Proteome Partnership - nominated targets
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
308 |
1,112 |
131 |
Expression tested |
|
  |
307 |
1,105 |
130 |
Expressed (E > 0) |
|
  |
260 |
766 |
122 |
Expressed-Soluble (S > 0) |
|
  |
201 |
431 |
117 |
Expressed-Soluble (ES >= 9) |
|
  |
171 |
338 |
108 |
Fermented |
|
  |
159 |
293 |
101 |
Purification attempted |
|
  |
115 |
206 |
78 |
Purified (>= 0.5 mg yield) |
|
  |
101 |
168 |
71 |
HSQC spectra recorded |
|
  |
29 |
53 |
22 |
"Good" HSQC spectra |
|
  |
10 |
22 |
7 |
HTP crystal screening |
|
  |
36 |
55 |
28 |
Crystal hit |
|
  |
9 |
13 |
8 |
X-Ray structures |
|
  |
2 |
2 |
2 | 2 |
NMR structures |
|
  |
4 |
4 |
3 | 4 |
Total structures |
|
  |
6 |
6 |
5 | 6 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Chaperone-Enabled Studies of Epigenetic Regulation Enzymes Partnership
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
219 |
875 |
90 |
Expression tested |
|
  |
217 |
870 |
90 |
Expressed (E > 0) |
|
  |
196 |
749 |
84 |
Expressed-Soluble (S > 0) |
|
  |
128 |
319 |
70 |
Expressed-Soluble (ES >= 9) |
|
  |
99 |
235 |
59 |
Fermented |
|
  |
110 |
209 |
73 |
Purification attempted |
|
  |
84 |
146 |
62 |
Purified (>= 0.5 mg yield) |
|
  |
65 |
104 |
52 |
HSQC spectra recorded |
|
  |
19 |
30 |
16 |
"Good" HSQC spectra |
|
  |
15 |
22 |
13 |
HTP crystal screening |
|
  |
9 |
12 |
9 |
Crystal hit |
|
  |
4 |
4 |
4 |
X-Ray structures |
|
  |
1 |
1 |
1 | 2 |
NMR structures |
|
  |
8 |
8 |
8 | 8 |
Total structures |
|
  |
9 |
9 |
9 | 10 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Protein Homeostatis Partnership
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions |
|
cloned |
|
  |
206 |
372 |
91 |
Expression tested |
|
  |
184 |
263 |
80 |
Expressed (E > 0) |
|
  |
151 |
208 |
72 |
Expressed-Soluble (S > 0) |
|
  |
119 |
167 |
64 |
Expressed-Soluble (ES >= 9) |
|
  |
90 |
131 |
50 |
Fermented |
|
  |
62 |
77 |
40 |
Purification attempted |
|
  |
56 |
70 |
37 |
Purified (>= 0.5 mg yield) |
|
  |
52 |
64 |
34 |
HSQC spectra recorded |
|
  |
10 |
13 |
6 |
"Good" HSQC spectra |
|
  |
5 |
6 |
3 |
HTP crystal screening |
|
  |
24 |
26 |
18 |
Crystal hit |
|
  |
7 |
9 |
7 |
X-Ray structures |
|
  |
0 |
0 |
0 | 0 |
NMR structures |
|
  |
1 |
1 |
1 | 1 |
Total structures |
|
  |
1 |
1 |
1 | 1 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-29]
Human transcription factors
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | HUGO ids |
|
cloned |
|
  |
2,849 |
4,395 |
1,833 | 1,784 |
Expressed (E > 0) |
|
  |
2,544 |
3,548 |
1,734 | 1,688 |
Expressed-Soluble (S > 0) |
|
  |
1,686 |
2,305 |
1,293 | 1,280 |
Expressed-Soluble (ES >= 9) |
|
  |
1,171 |
1,633 |
962 | 957 |
Purified (>= 0.5 mg yield) |
|
  |
1,259 |
1,416 |
1,155 | 1,114 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
Bet v1-like super family
Production stage |
|
|
NESG targets |
distinct constructs |
UniProt ids | depositions | NMR & Xray |
|
cloned |
|
  |
242 |
335 |
196 |
Expression tested |
|
  |
241 |
331 |
195 |
Expressed (E > 0) |
|
  |
206 |
276 |
169 |
Expressed-Soluble (S > 0) |
|
  |
168 |
218 |
149 |
Expressed-Soluble (ES >= 9) |
|
  |
141 |
177 |
129 |
Fermented |
|
  |
117 |
157 |
109 |
Purification attempted |
|
  |
109 |
140 |
103 |
Purified (>= 0.5 mg yield) |
|
  |
102 |
131 |
98 |
HSQC spectra recorded |
|
  |
79 |
92 |
78 |
"Good" HSQC spectra |
|
  |
63 |
74 |
63 |
HTP crystal screening |
|
  |
56 |
68 |
56 |
Crystal hit |
|
  |
37 |
40 |
37 |
X-Ray structures |
|
  |
18 |
18 |
18 | 18 |
NMR structures |
|
  |
20 |
20 |
20 | 23 | 2 |
Total structures |
|
  |
36 |
36 |
36 | 41 |
[top statuses] [efficiency plots] [weekly progress] [topBins (targets)] [attrition table created 2016-04-30]
|